M

Mustang Bio

D
MBIO
USD
0.0104
(4.5296%)
Market Closed
53,933.00
Volume
-0.91
EPS
-
Div Yield
-0.088235
P/E
8,935,829.04
Market Cap
Today
-0.9083%
1 Week
-15.789%
1 Month
8.011%
6 Months
-14.286%
12 Months
-87.166%
Year To Date
-82.353%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
A
ADUS
-1.09
(-0.8384%)
USD
I
INO
-0.13
(-2.2968%)
USD
O
OPK
-0.02
(-1.3605%)
USD
V
VBIV
(%)
USD
V
VXRT
0.0125
(1.7576%)
USD
C
CODX
-0.035
(-2.8926%)
USD

Title:
Mustang Bio

Sector:
Healthcare
Industry:
Biotechnology
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipelineis currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
Do you need help or have a question?
Contact Us